Department of Gynaecological Oncology, Liverpool Womens NHS Foundation Trust, Liverpool, United Kingdom.
J Palliat Med. 2010 Mar;13(3):251-4. doi: 10.1089/jpm.2009.0158.
Ascites is frequently seen in patients suffering with ovarian cancer. Paracentesis is a well-established method to provide symptomatic relief. Systemic adverse effects have occurred in paracentesis for ascites arising from other conditions. However, malignancy-related ascites has a different pathophysiology than nonmalignant ascites and as such the concerns related to the latter condition may not apply in patients with ovarian cancer. This study has shown that paracentesis is both effective and safe as an outpatient procedure for managing malignancy-related ascites.
腹水在卵巢癌患者中很常见。腹腔穿刺术是一种已被广泛认可的方法,可以提供症状缓解。其他原因引起的腹水行腹腔穿刺术时会出现全身不良反应。然而,与恶性肿瘤相关的腹水与非恶性腹水的病理生理学机制不同,因此后者的相关问题可能不适用于卵巢癌患者。本研究表明,对于管理与恶性肿瘤相关的腹水,腹腔穿刺术作为一种门诊操作,既有效又安全。